|
1
|
da Silva EZ, Jamur MC and Oliver C: Mast
cell function: A new vision of an old cell. J Histochem Cytochem.
62:698–738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ekoff M and Nilsson G: Mast cell apoptosis
and survival. Adv Exp Med Biol. 716:47–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Valent P, Akin C, Arock M, Brockow K,
Butterfield JH, Carter MC, Castells M, Escribano L, Hartmann K,
Lieberman P, et al: Definitions, criteria and global classification
of mast cell disorders with special reference to mast cell
activation syndromes: A consensus proposal. Int Arch Allergy
Immunol. 157:215–225. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wygrecka M, Dahal BK, Kosanovic D,
Petersen F, Taborski B, von Gerlach S, Didiasova M, Zakrzewicz D,
Preissner KT, Schermuly RT and Markart P: Mast cells and
fibroblasts work in concert to aggravate pulmonary fibrosis: Role
of transmembrane SCF and the PAR-2/PKC-alpha/Raf-1/p44/42 signaling
pathway. Am J Pathol. 182:2094–2108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karlberg M, Ekoff M, Huang DC, Mustonen P,
Harvima IT and Nilsson G: The BH3-mimetic ABT-737 induces mast cell
apoptosis in vitro and in vivo: Potential for
therapeutics. J Immunol. 185:2555–2562. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Picard M, Giavina-Bianchi P, Mezzano V and
Castells M: Expanding spectrum of mast cell activation disorders:
Monoclonal and idiopathic mast cell activation syndromes. Clin
Ther. 35:548–562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Overed-Sayer C, Rapley L, Mustelin T and
Clarke DL: Are mast cells instrumental for fibrotic diseases? Front
Pharmacol. 4:1742014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harvima IT and Nilsson G: Stress, the
neuroendocrine system and mast cells: Current understanding of
their role in psoriasis. Expert Rev Clin Immunol. 8:235–241. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Benoist C and Mathis D: Mast cells in
autoimmune disease. Nature. 420:875–878. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun J, Sukhova GK, Wolters PJ, Yang M,
Kitamoto S, Libby P, MacFarlane LA, Mallen-St Clair J and Shi GP:
Mast cells promote atherosclerosis by releasing proinflammatory
cytokines. Nat Med. 13:719–724. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Soucek L, Lawlor ER, Soto D, Shchors K,
Swigart LB and Evan GI: Mast cells are required for angiogenesis
and macroscopic expansion of Myc-induced pancreatic islet tumors.
Nat Med. 13:1211–1218. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Melo FR, Waern I, Rönnberg E, Åbrink M,
Lee DM, Schlenner SM, Feyerabend TB, Rodewald HR, Turk B,
Wernersson S and Pejler G: A role for serglycin proteoglycan in
mast cell apoptosis induced by a secretory granule-mediated
pathway. J Biol Chem. 286:5423–5433. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lessene G, Czabotar PE and Colman PM:
BCL-2 family antagonists for cancer therapy. Nat Rev Drug Discov.
7:989–1000. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bradding P, Walls AF and Holgate ST: The
role of the mast cell in the pathophysiology of asthma. J Allergy
Clin Immunol. 117:1277–1284. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu C, Mei J, Li D, Liu J, Qin H, Liu F and
Zhao D: Expression of microRNA in murine model induced by
ovalbumin. Shi Yong Er Ke Lin Chuang Za Zhi. 21:1655–1657. 2012.(In
Chinese).
|
|
16
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: MicroRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pan Y, Liang H, Liu H, Li D, Chen X, Li L,
Zhang CY and Zen K: Platelet-secreted microRNA-223 promotes
endothelial cell apoptosis induced by advanced glycation end
products via targeting the insulin-like growth factor 1 receptor. J
Immunol. 192:437–446. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
LeRoith D and Roberts CT Jr: The
insulin-like growth factor system and cancer. Cancer Lett.
195:127–137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pollak MN, Schernhammer ES and Hankinson
SE: Insulin-like growth factors and neoplasia. Nat Rev Cancer.
4:505–518. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Samani AA, Yakar S, LeRoith D and Brodt P:
The role of the IGF system in cancer growth and metastasis:
Overview and recent insights. Endocr Rev. 28:20–47. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Adams TE, Epa VC, Garrett TP and Ward CW:
Structure and function of the type 1 insulin-like growth factor
receptor. Cell Mol Life Sci. 57:1050–1093. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang B, Sun F, Dong N, Sun Z, Diao Y,
Zheng C, Sun J, Yang Y and Jiang D: MicroRNA-7 directly targets
insulin-like growth factor 1 receptor to inhibit cellular growth
and glucose metabolism in gliomas. Diagn Pathol. 19:2112014.
View Article : Google Scholar
|
|
25
|
Guo T, Feng Y, Liu Q, Yang X, Jiang T,
Chen Y and Zhang Q: MicroRNA-320a suppresses in GBM patients and
modulates glioma cell functions by targeting IGF-1R. Tumor Biol.
35:11269–11275. 2014. View Article : Google Scholar
|
|
26
|
Zhang Y, Chen X, Lian H, Liu J, Zhou B,
Han S, Peng B, Yin J, Liu W and He X: MicroRNA-503 acts as a tumor
suppressor in glioblastoma for multiple antitumor effects by
targeting IGF-1R. Oncology Reports. 31:1445–1452. 2014.PubMed/NCBI
|
|
27
|
Farhana L, Dawson MI, Murshed F, Das JK,
Rishi AK and Fontana JA: Upregulation of miR-150* and miR-630
induces apoptosis in pancreatic cancer cells by targeting IGF-1R.
PLoS One. 8:e610152013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu JW, Wang TX, You L, Zheng LF, Shu H,
Zhang TP and Zhao YP: Iusulin-like growth factor 1 receptor
(IGF-1R) as a target of miR-497 and plasma IGF-1R levels associated
with TNM stage of pancreatic cancer. PloS One. 9:e928472014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang K, Dong X, Sui C, Hu D, Xiong T,
Liao S and Zhang H: MiR-223 suppresses endometrial carcinoma cells
proliferation by targeting IGF-1R. Am J Transl Res. 6:841–849.
2014.PubMed/NCBI
|
|
30
|
Gerbaulet A, Hartmann K and Mekori YA:
Mast cell apoptosis. Methods Mol Biol. 315:407–423. 2006.PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hara K, Ueda S, Ohno Y, Tanaka T, Yagi H,
Okazaki S, Kawahara R, Masayuki T, Enomoto T, Hashimoto Y, et al:
NIH3T3 cells overexpressing CD98 heavy chain resist early G1 arrest
and apoptosis induced by serum starvation. Cancer Sci.
103:1460–1466. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang W, Ye D, Dai L, Shen Y and Xuu J:
Overexpression of hTERT extends replicative capacity of human
nucleus pulposus cells, and protects against serum
starvation-induced apoptosis and cell cycle arrest. J Cell Biochem.
113:2112–2121. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen J, Hou R, Zhang X, Ye Y, Wang Y and
Tian J: Calycosin suppresses breast cancer cell growth via
ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
PloS One. 9:e912452012. View Article : Google Scholar
|
|
35
|
Ohtani M, Numazaki M, Yajima Y and
Fujita-Yamaguchi Y: Mechanisms of antibody-mediated insulin-like
growth factor I receptor (IGF-IR) down-regulation in MCF-7 breast
cancers. Biosci Trends. 3:131–138. 2009.PubMed/NCBI
|
|
36
|
Zhao Y, Wang Z, Jiang Y and Yang C:
Inactivation of Rac 1 reduces Trastuzumab resistance in PTEN
deficient and insulin-like growth factor I receptor overexpressing
human breast cancer SKBR3 cells. Cancer Lett. 313:54–63. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pollak M: The insulin and insulin-like
growth factor receptor family in neoplasia: An update. Nat Rev
Cancer. 12:159–169. 2012.PubMed/NCBI
|
|
38
|
Johnnidis JB, Harris MH, Wheeler RT,
Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD and
Camargo FD: Regulation of progenitor cell proliferation and
granulocyte function by microRNA-223. Nature. 451:1125–1129. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Haneklaus M, Gerlic M, O'Neill LA and
Masters SL: MiR-223: Infection, inflammation and cancer. J Intern
Med. 274:215–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vian L, Di Carlo M, Pelosi E, Fazi F,
Santoro S, Cerio AM, Boe A, Rotilio V, Billi M, Racanicchi S, et
al: Transcriptional fine-tuning of microRNA-223 levels directs
lineage choice of human hematopoietic progenitors. Cell Death
Differ. 21:290–301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Laios A, O'Toole S, Flavin R, Martin C,
Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, et al:
Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Mol Cancer. 7:352008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Løvendorf MB, Zibert JR, Gyldenløve M,
Røpke MA and Skov L: MicroRNA-223 and miR-143 are important
systemic biomarkers for disease activity in psoriasis. J Dermatol
Sci. 75:133–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gottardo F, Liu CG, Ferracin M, Calin GA,
Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, et
al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang J, Luo X, Li H, Yue X, Deng L, Cui Y
and Lu Y: MicroRNA-223 functions as an oncogene in human colorectal
cancer cells. Oncol Rep. 32:115–120. 2014.PubMed/NCBI
|
|
45
|
Li ZW, Yang YM, Du LT, Dong Z, Wang LL,
Zhang X, Zhou XJ, Zheng GX, Qu AL and Wang CX: Overexpression of
miR-223 correlates with tumor metastasis and poor prognosis in
patients with colorectal cancer. Med Oncol. 31:2562014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang H, Yin Z, Ning K, Wang L, Guo R and
Ji Z: Prognostic value of microRNA-223/epithelial cell transforming
sequence 2 signaling in patients with osteosarcoma. Hum Pathol.
45:1430–1436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li G, Cai M, Fu D, Chen K, Sun M, Cai Z
and Cheng B: Heat shock protein 90B1 plays an oncogenic role and is
a target of microRNA-223 in human osteosarcoma. Cell Physiol
Biochem. 30:1481–1490. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ma L, Chen Y, Zhang B and Liu G: Increased
microRNA-223 in Helicobacter pylori-associated gastric cancer
contributed to cancer cell proliferation and migration. Biosci
Biotechnol Biochem. 78:602–608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pulikkan JA, Dengler V, Peramangalam PS,
Peer Zada AA, Müller-Tidow C, Bohlander SK, Tenen DG and Behre G:
Cell-cycle regulator E2F1 and microRNA-223 comprise an
autoregulatory negative feedback loop in acute myeloid leukemia.
Blood. 115:1768–1778. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Harraz MM, Eacker SM, Wang X, Dawson TM
and Dawson VL: MicroRNA-223 is neuroprotective by targeting
glutamate receptors. Proc Natl Acad Sci USA. 109:18962–18967. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kang W, Tong JH, Chan AW, Lung RW, Chau
SL, Wong QW, Wong N, Yu J, Cheng AS and To KF: Stathmin1 plays
oncogenic role and is a target of microRNA-223 in gastric cancer.
PLoS One. 7:e339192012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jia CY, Li HH, Zhu XC, Dong YW, Fu D, Zhao
QL, Wu W and Wu XZ: MiR-223 suppresses cell proliferation by
targeting IGF-1R. PLoS One. 6:e270082011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wu LH, Cai QQ, Dong YW, Wang R, He BM, Qi
B, Xu CJ and Wu XZ: Decoy oligonucleotide rescues IGF1R expression
from MicroRNA-223 suppression. PLoS One. 8:e821672013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yu YH, Zhang L, Wu DS, Zhang Z, Huang FF,
Zhang J, Chen XP, Liang DS, Zeng H and Chen FP: MiR-223 regulates
human embryonic stem cell differentiation by targeting the
IGF-1R/Akt signaling pathway. PLoS One. 8:e787692013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Rodriguez-Viciana P, Warner PH, Khwaja A,
Marte BM, Pappin D, Das P, Waterfield MD, Ridley A and Downward J:
Role of phosphoinositide 3-OH kinase in cell transformation and
control of the actin cytoskeleton by Ras. Cell. 89:457–467. 1997.
View Article : Google Scholar : PubMed/NCBI
|
